¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Journal of environmental polymer degradation."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® environmental pollution ÇÑ±Û È¯°æ¿À¿°
¼³¸í   
  Àΰ£È°µ¿¿¡ ÀÇÇØ ¹ß»ýÇϴ ´ë±â-¼öÁú-Åä¾ç ¿À¿° ¹× ¼ÒÀ½-Áøµ¿ µîÀ¸·Î ÀÚ¿¬È¯°æÀ̳ª »ýȰȯ°æÀ» ¼Õ»ó½Ã۴ Çö»ó. °øÀå-»ç¾÷À堵 »ý»êȰµ¿, ÀÚµ¿Â÷-±âÂ÷-Ç×°ø±â-¼±¹Ú µîÀÇ ¼ö¼ÛȰµ¿, ³Ã³­¹æ-Ãë»ç-¿©°¡¼±¿ë µî ÀÏ»ó»ýȰÀ» Æ÷ÇÔÇÑ °¢Á¾ Àΰ£ È°µ¿¿¡ ÀÇÇØ À¯¹ßµÇ´Â ÀÎÀ§ÀûÀΠ´ë±â¿À¿°- ¼öÁú¿À¿°-Åä¾ç¿À¿°-¼ÒÀ½-Áøµ¿-Áö¹ÝħÇÏ-¾ÇÃë µîÀÇ ¹ß»ýÀ¸·Î ÀÚ¿¬È¯°æÀ̳ª »ýȰȯ°æÀ» ¼Õ»ó½ÃŰ°í ±Ã±ØÀûÀ¸·Î´Â »ç¶÷ÀÇ »ýȰ ¹× °Ç°­¿¡ À¯ÇØÇÑ ¿µÇâÀ» ¹ÌÄ¡´Â Çö»óÀ» ¸»ÇÑ´Ù. À̴ ƯÈ÷, »ê¾÷Çõ¸í ÀÌÈÄ¿¡ µÎµå·¯Áö°Ô ³ªÅ¸³µÀ¸¸ç, Àΰ£È°µ¿ÀÌ ÁÖ¾îÁø È¯°æ°ø°£ÀÇ °íÀ¯ÇÑ ÀÚÁ¤´É·ÂÀ» ÃʰúÇÒ °æ¿ì ¹ß»ýÇÑ´Ù. Áö±Ýµµ °øÇضó°í Ç¥ÇöÇϴ »ç¶÷ÀÌ ÀÖÀ¸³ª ÇöÀç´Â È¯°æ¿À¿°À̶ó´Â ¿ë¾î°¡ Ç¥ÁØ¿ë¾î°¡ µÇ¾ú´Ù. °øÇضó´Â ³¹¸»ÀÇ ¾î¿øÀº ¿µ±¹ÀÇ °øÁߺҹý¹æÇØ¿¡¼­ ºñ·ÔµÇ¾ú´Ù°í ÇÑ´Ù. ±×·¯³ª °øÇضó´Â ¸»Àº ÁַΠÀϺ»¿¡¼­ ¾²À̰í ÀÖÀ» »Ó ±¹Á¦ÀûÀ¸·Îµµ È¯°æ¿À¿°À̶ó°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • journal
    1. ÇмúÁö 2. Àϱâ
  • degradation
    ºÐÇØ, ÅðÇà, ºØ±«
  • degradation product
    ºÐÇØ»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°, ÇǺ기ºÐÇØ»ê¹°
  • fibrinogen degradation products
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
  • oxidative degradation
    »êÈ­ºÐÇØ
  • addition polymer
    ºÎ°¡ÁßÇÕü
  • bioadhesive polymer
    »ýü°áÇÕ¼ºÁßÇÕü
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ
  • hydration polymer
    ¼öÈ­ÁßÇÕü
  • polymer
    秂͟
  • polymer molecule
    ÁßÇÕüºÐÀÚ
  • environmental antigen
    ȯ°æÇ׿ø
  • environmental assessment
    ȯ°æÆò°¡
  • environmental deprivation
    ȯ°æ¹æÇØ, ȯ°æ¹ÚÅ»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • journal
    1. ÇмúÁö, 2. Àϱâ
  • polymer
    秂͟
  • degradation
    ºÐÇØ, ÅðÇà, ºØ±«
  • fibrinogen degradation products product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ, ÅðÇà, ºØ±«
  • degradation product
    ºÐÇØ»ê¹°
  • oxidative degradation
    »êÈ­ºÐÇØ
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • addition polymer
    ºÎ°¡ÁßÇÕ¹°
  • bioadhesive polymer
    »ýü°áÇÕ¼º°íºÐÀÚ
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ
  • hydration polymer
    ¼öÈ­ÁßÇÕü
  • polymer molecule
    ÁßÇÕüºÐÀÚ
  • polymer
    秂͟
  • environmental antigen
    ȯ°æÇ׿ø
  • environmental assessment
    ȯ°æÆò°¡
  • environmental pollution control
    ȯ°æ¿À¿°°ü¸®
  • environmental deprivation
    ȯ°æ¹æÇØ, ȯ°æ¹ÚÅ»
  • environmental engineering
    ȯ°æ°øÇÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • addition polymer
    ºÎ°¡ÁßÇÕ¹°(¡­ñìùêÚª).
  • graft polymer
    À̽ÄÁßÇÕü.
  • high polymer
    °íÁßÇÕü(ÍÔñìùêô÷).
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ(ÍÔÝÂí­ûùùÊ).
  • polymer
    Æú¸®¸Ó, ÁßÇÕü(ñìùêô÷).
  • polymer
    秂͟
  • polymer molecule
    ÁßÇÕüºÐÀÚ(ñìùêô÷ÝÂí­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºØ±«
  • degradation
    ºÐÇØ, ÅðÇà.
  • degradation
    ºÐÇØ, ÅðÇà(÷Üú¼).
  • degradation product
    ºÐÇØ»ê¹°(ÝÂú°ß§Úª)
  • degradation senile
    ³ëÀμº ÅðÈ­.
  • fibrin degradation product
  • fibrin degradation products =fDP
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products=FDP
    ¼¶À¯¼Ò¿ø ºÐÇØ»ê¹°
  • oxidative degradation
    »êÈ­Àû ºÐÇØ(¹ÝÀÀ) (¡­ÝÂú°Úãëë).
  • addition polymer
    ºÎ°¡ÁßÇÕ¹°(¡­ñìùêÚª).
  • bioadhesive polymer
    »ýü°áÇÕ¼º °íºÐÀÚ(ÍÔÝÂí­).
  • graft polymer
    À̽ÄÁßÇÕü.
  • high polymer
    °íÁßÇÕü(ÍÔñìùêô÷).
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ(ÍÔÝÂí­ûùùÊ).
  • hydration polymer
    ¼öÈ­ÁßÇÕü.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Environmental cause
    ȯ°æ¿øÀÎ
    [¿¾ ¿ë¾î] ȯ°æÀû¿øÀÎ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ(ÝÂú°)
  • detergent degradation
    "¼¼Á¦ºÐÇØ(á©ð¥ÝÂú°), (ÔÒ) biodegradable"
  • Edman degradation
    ¿¡µå¸¸ ºÐÇØ(ÝÂú°)
  • Fischer-MacDonald degradation
    ÇǼÅ-¸Æµµ³Îµå ºÐÇØ(ÝÂú°)
  • Ruff degradation
    ·çÇÁ ºÐÇØ(ÝÂú°)
  • Smith degradation
    ½º¹Ì½º ºÐÇØ(ÝÂú°)
  • subtractive Edman degradation
    Á¦°Å (ð¶ËÛ) ¿¡µå¸¸ºÐÇØ (ÝÂú°)
  • Wohl-Zemplen degradation
    º¼-ÁªÇ÷» ºÐÇØ (ÝÂú°)
  • addition polymer
    ºÎ°¡ÁßÇÕü(ݾʥñìùêô÷)
  • aperiodic polymer
    ºñÁÖ±âÀû(ÞªñÎÑ¢îÜ) ÁßÇÕü(ñìùêô÷)
  • atactic polymer
    ¾ÆÅ¹Æ®ÁßÇÕü(ñìùêô÷)
  • branched polymer
    ºÐÁöÁßÇÕü(ÝÂò«ñìùêô÷)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • condensation polymer
    ÃàÇÕ ÁßÇÕü(õêùêñìùêô÷)
  • fibrin polymer
    ¼¶À¯¼Ò ÁßÇÕü(àéë«áÈñìùêô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ, ÅðÇà
  • environmental hygiene
    ȯ°æÀ§»ý
  • polymer
    Æú¸®¸Ó, ÁßÇÕü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FDP fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra...
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
DHP dehydrogenated polymer; dihydroprogesterone; 1,4-dihydropyridine
poly-IC, poly-I:C copolymer of polyinosinic and polycytidylic acids; synthetic RNA polymer
AJKD American Journal of Kidney Diseases
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JAMA Journal of the American Medical Association
NEJM New England Journal of Medicine
IPN Interpenetrating polymer network
MIP Molecularly imprinted polymer
GP glucose polymer
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 20355
    JournalTitle: Journal of environmental polymer degradation.
    MedAbbr:
    ISSN: 1064-7546
    ESSN:
    IsoAbbr: J. Environ. Polym. Degrad.
    NlmId: 100955198
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • medical journal
    ÀÇÇÐÀâÁö, ÀÇÇÐÇмúÁö
  • degradation product
    ºÐÇØ »ê¹°
  • marginal degradation
    º¯¿¬ ºØ±«
  • bioadhesive polymer
    »ýü°áÇÕ¼º °íºÐÀÚ
  • D-amino acid polymer
    D-¾Æ¹Ì³ë»ê ÁßÇÕü
    D-amino »ê¿¡¼­ ÇÕ¼ºÇÏ¿© ¸¸µé¾îÁø Ç׿ø¼ºÀÌ °­ÇÑ ÆéŸÀ̵å, ¶Ç´Â Æú¸® ÆéŸÀ̵å.
  • insoluble polymer
    ºÒ¿ë¼º ÁßÇÕÁ¦
  • linear polymer
    ¼±»ó ÁßÇÕü
    ºÐÀÚÀÇ Çü»óÀÌ »ç»óÀÎ ÁßÇÕ¹°·Î ºÐÁöÇÑ ÁßÇÕ¹°, ȤÀº °¡°øµÈ ÁßÇÕ¹°¿¡ ´ëºñµÈ´Ù´Â ¶æ.
  • polymer
    ÁßÇÕü, ·¹Áø ºÐ¸»
    1. ´õ ÀÛÀº ´Ü·®Ã¼ÀÇ ¹Ýº¹¿¡ ÀÇÇØ Å« À¯±â ºÐÀÚü¸¦ Çü¼ºÇÏ´Â È­ÇÐÀûÀÎ È­ÇÕ¹°. 2. ´Ü·®Ã¼°¡ ¹Ýº¹ °áÇÕÇÏ¿© »ý¼ºµÈ °íºÐÀÚ È­ÇÕ¹°.
  • polymer tag
    ÁßÇÕü µ¹Ãâ¹°, ÁßÇÕü µ¹±â
  • environmental chemotactic factor
    ȯ°æ¼º È­ÇÐ ÁÖ¼º ÀÎÀÚ
  • environmental contingency
    ȯ°æ ¿äÀÎ
  • environmental damage
    ȯ°æ ÇÇÇØ
  • environmental deterioration
    ȯ°æ ¾ÇÈ­, ȯ°æ ÆÄź
  • environmental engineering
    ȯ°æ °øÇÐ
  • environmental hazard
    ȯ°æ ÀçÇØ, ȯ°æ ÀåÇØ, ȯ°æÀû À§ÇØ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
journal article The predominant publication type for articles and other items indexed for nlm databases.
(12 Dec 1998)
addition polymer <chemistry> A polymer which is formed from the fusion of two monomers which join completely without losing any small molecules.
(15 Jan 1998)
condensation polymer <chemistry> The kind of polymer that is formed by the combination of monomers and the release of a small molecules at the point where monomers are joined.
(05 Jan 1998)
polymer <chemistry> A macromolecule made of repeating (monomer) units or protomers.
(18 Nov 1997)
polymer fume fever An occupational disease marked by fever, pain in the chest, and cough caused by the inhalation of fumes given off by a plastic, polytetrafluorethylene, when heated.
(05 Mar 2000)
degradation <biochemistry, chemistry> The reduction of a chemical compound to one less complex, as by splitting off one or more groups.
(18 Nov 1997)
edman degradation A lab technique used to find out the order of amino acids in a polypeptide (chain of amino acids). It involves using the Edman reagent, phenyl isothiocyanate (PITC), to react one by one with each amino acid, in order. The technique is used in machines which automatically sequence (determine the order of subunits) polypeptides.
(09 Oct 1997)
fibrin degradation products <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot.
Normal value is less than 10 mcg/ml (micrograms per millilitre).
They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia.
Acronym: FDP
(23 Sep 2002)
fibrin fibrinogen degradation products <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis.
Pharmacological action: antithrombins.
(12 Dec 1998)
air pollutants, environmental Air pollutants which affect environmental conditions.
(12 Dec 1998)
carcinogens, environmental Carcinogenic substances that are found in the environment.
(12 Dec 1998)
national environmental policy act A federal law enacted in 1969 that requires all federal agencies to consider and analyse the environmental impacts of any proposed action. NEPA requires an environmental impact statement for major federal actions significantly affecting the quality of the environment. NEPA requires federal agencies to inform and involve the public in the agency's decision making process and to consider the environmental impacts of the agency's decision.
(05 Dec 1998)
draft environmental impact statement (DEIS) A draft statement of environmental effects. Section 102 of the National Environmental Policy Act requires a DEIS for all major federal actions. The DEIS is released to the public and other agencies for comment and review.
(05 Dec 1998)
environmental assessment (EA) A public document that analyzes a proposed federal action for the possibility of significant environmental impacts. The analysis is required by NEPA. If the environmental impacts will be significant, the federal agency must then prepare an environmental impact statement.
(05 Dec 1998)
environmental exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    °ÝÇÏ;ÁÂõ;¸éÁ÷;Ÿ¶ô;ÀúÇÏ;ħ½Ä;ºÐÇØ
  • degradation
    ÁÂõ;ÆÄ¸é;Àú¶ô;Ç϶ô;Åðº¸
  • journal
    Àϱâ
  • high polymer
    °íºÐÀÚ(°Å´ëºÐÀÚ) ¹°Áú
  • high polymer chemistry
    °íºÐÀÚ(È­)ÇÐÀÇ;°­·ÂÇÑ;(±¤ÇÐ ±â±â°¡)¹èÀ²ÀÌ ³ôÀº;Á¤·ÂÀûÀÎ
  • journal
    ÀÏÁö;Ç×ÇØ ÀÏÁö;ºÐ°³Àå;(Àϰ£)½Å¹®;(Á¤±â °£Çà)ÀâÁö;±¼´ëÀÇ ¸ñ;the Journals ±¹È¸ ÀÇ»ç·Ï
  • polymer
    秂͟
  • purchase journal
    ±¸ÀÔ ÀϰèÀå
  • Environmental Protection Agency
    (¹Ì)ȯ°æ º¸È£±¹
  • environmental
    ȯ°æÀÇ;ÁÖÀ§ÀÇ;ȯ°æ¿¹¼úÀÇ(environmental pollution ȯ°æ ¿À¿°)
  • environmental art
    ȯ°æ ¿¹¼ú(°ü°´À» Æ÷ÇÔÇÏ´Â Á¾ÇÕ ¿¹¼ú)
  • environmental assessment
    ȯ°æ »çÀü Á¶»ç
  • environmental biology
    ȯ°æ »ý¹°ÇÐ;»ýÅÂÇÐ
  • environmental disruption
    ȯ°æ ÆÄ±«
  • environmental engineer
    ȯ°æ °øÇÐÀÚ(ȯ°æ º¸ÀüÀÇ Àü¹® ±â¼úÀÚ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á